[1] Agnello F.,
Selvaggio G.
et al. Imaging appearance of treated hepatocellular carcinoma,
World J Hepatol,
2013; 5(8): 417-424
[2] Aubè C.,
Oberti F.
et al.
Radiological treatment of hcc: interventional radiology at the heart of management,
Diagn Interv Imaging 2015; 96(6): 625-636
[3] Llovet JM,
Ducreux M.
et al.
EASL-EORTC clinical practice guidelines: man-agement of hepatocellular carcinoma.
Eur J Cancer 2012; 48(5): 599-641
[4] Kinoshita A.,
Onoda H.
et al.
Staging systems for hepatocellular carcinoma: current status and future perspectives,
World J Hepatol 2015;7(3): 406-424
[5] Adam A.
Interventional radiology in the treatment of hepatic metastases,
Cancer Treat Rev,
2002; 28: 93-99
[6] Barabasch A.,
Nils A.
et al.
Diagnostic Accuracy of Diffusion-Weighted Magnetic Resonance Imaging Versus Positron Emission Tomography/Computed Tomography for Early Response Assessment of Liver Metastases to Y90-Radioembolization,
Invest Radiol.
2015; 50:409-415
[7] Kuhlmann JB,
Blum HE.
Locoregional therapy for cholangiocarcinoma,
Curr Opin Gastroenterol,
2013,
29(3): 324-328
[8] Kim HJ,
Kim TK et al.
Assessment of the therapeutic response of hepatocellular carcinoma
treated with transcatheter arterial chemoembolization: comparison of contrast enhanced sonography and 3-phase computed tomography.
J Ultrasound Med 2006; 25:477–486
[9] Özkavukcu E.,
Haliloglu N.,
Erden A.
Post-treatment MRI findings of hepatocellular carcinoma,
Diagn Interv Radiol,
2009; 15(2): 111-120
[10] Willatt J.,
Ruma JA et al.
Imaging of hepatocellular carcinoma and image guided therapies - how we do it,
Cancer Imaging 2017; 17:9
[11] Boas FE,
Do B.
et al.
Optimal Imaging Surveillance Schedules after Liver-Directed Therapy for Hepatocellular Carcinoma,
J Vasc Interv Radiol 2015; 26:69–73
[12] Yaghmai V.,
Besa C.
et al.
Imaging Assessment of Hepatocellular Carcinoma Response to Locoregional and Systemic Therapy,
AJR 2013; 201:80–96
[13] Guan YS,
Sun L et al.
Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up,
World J Gastroenterol.
2004,
10 (24): 3543-3548
[14] Livraghi T.,
Goldberg SN et al.
Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions,
Radiology 2000;214(3): 761-768
[15] Winters SD,
Jackson S.
et al.
Value of subtraction MRI in assessing treatment response following image-guided loco-regional therapies for hepatocellular carcinoma,
Clin Radiol.
2012; 67(7): 649-655
[16] Marin D.,
Cappabianca S.
et al.
CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review,
Gastroenterology Research and Practice 2015; :-
[17] Chung WS,
Lee KH et al.
Enhancement pattern of hepatocellular carcinoma after Transarterial Chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study,
AJR 2012;199: 349-359
[18 ] Chung JC,
Naik NK et al.
Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization,
World J Gastroenterol.
2010; 16(25): 3161-3167
[19 ] Halappa VG,
Bonekamp S.
et al.
Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response,
Radiology 2012; 264: 285-294